Morphic Holding, Inc. Common Stock
MORF
MORF was delisted on the 15th of August, 2024.
129 hedge funds and large institutions have $1.15B invested in Morphic Holding, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 35 increasing their positions, 46 reducing their positions, and 17 closing their positions.
409% more call options, than puts
Call options by funds: $19.6M | Put options by funds: $3.84M
100% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 17
39% more capital invested
Capital invested by funds: $823M → $1.15B (+$323M)
15% more funds holding
Funds holding: 112 → 129 (+17)
24% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 46
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.3M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$12M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$11M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$10.6M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$7.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$19.3M |
| 2 |
State Street
Boston,
Massachusetts
|
-$17.1M |
| 3 |
AG
Artal Group
Luxembourg
|
-$12.4M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.3M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$10.6M |
MORF Hedge Fund Activity: Q1 2023 in Review
129 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Morphic Holding, Inc. Common Stock (MORF) for Q1 2023, worth a combined $1.15B — up 39% from $823M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new MORF positions and 17 closed out — a net gain of 17 holders — while 35 added to existing stakes and 46 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $13.3M. The largest seller was Marshall Wace, cutting an estimated $19.3M.
- 129 institutional investors held Morphic Holding, Inc. Common Stock (MORF) as of Q1 2023, up from 112 in Q4 2022.
- Funds reported $1.15B of Morphic Holding, Inc. Common Stock stock for Q1 2023, up 39% quarter-over-quarter.
- 34 funds opened new Morphic Holding, Inc. Common Stock positions in Q1 2023 and 17 closed out, a net change of +17 holders.
- The largest Morphic Holding, Inc. Common Stock buyer in Q1 2023 was T. Rowe Price Associates, an estimated $13.3M added.
- The largest Morphic Holding, Inc. Common Stock seller in Q1 2023 was Marshall Wace, an estimated $19.3M sold.
Based on aggregated 13F filings for Q1 2023.